Status:

RECRUITING

Periodontal Regeneration With Hyaluronic Acid or Enamel Matrix Derivatives

Lead Sponsor:

University of Turin, Italy

Conditions:

Periodontitis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

To date, the quest for ideal biological inductors for periodontal regeneration is still ongoing, especially when facing non-containing defect anatomies. The primary aim of this study is to evaluate th...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Diagnosis of stage III-IV periodontitis.
  • Completed steps I-II periodontal therapy.
  • FMPS \<15% at 3-month re-evaluation.
  • FMBS \<15% at 3-month re-evaluation.
  • At least one site with intrabony defects and residual PPD ≥ 6 mm at re-evaluation, with a radiographic intrabony component ≥ 3 mm, and limited to no extension of the defect on the lingual or palatal side as assessed by preoperative bone sounding.
  • Intrasurgically, the defect has to present a non-supporting anatomy (1-2 residual walls in its most coronal portion) and it needs to be accessible by flap elevation only on one side (either buccal or oral).
  • Signed informed consent.
  • Exclusion criteria:
  • Compromised general health which contraindicates the study procedures (ASA III-VI patients).
  • Systemic diseases/medications which could influence the outcome of the therapy (e.g. uncontrolled diabetes mellitus, non-plaque-induced gingival diseases, antiepileptic drugs (phenytoin and sodium valproate), certain calcium channel-blocking drugs (e.g., nifedipine, verapamil, diltiazem, amlodipine, felodipine), immunoregulating drugs (e.g., ciclosporine), and high-dose oral contraceptives).
  • Current smokers (self-reported, ≥ 10 cigarettes a day), users of chewing tobacco, and drug/alcohol abusers.
  • Pregnant or nursing women.
  • Presence of furcation involvement ≥ II degree (Hamp 1975) at the affected teeth.

Exclusion

    Key Trial Info

    Start Date :

    October 1 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    October 1 2026

    Estimated Enrollment :

    60 Patients enrolled

    Trial Details

    Trial ID

    NCT06105112

    Start Date

    October 1 2023

    End Date

    October 1 2026

    Last Update

    October 27 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    CIR Dental School

    Turin, Italy, 10126

    Periodontal Regeneration With Hyaluronic Acid or Enamel Matrix Derivatives | DecenTrialz